Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).
about
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).
@en
Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).
@nl
type
label
Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).
@en
Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).
@nl
prefLabel
Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).
@en
Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).
@nl
P2093
P2860
P1433
P1476
Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).
@en
P2093
Adriano Gravina
Agata Pisano
Alessio Fabozzi
Anna Diana
Antonio Febbraro
Carmela Mocerino
Enrico Barbato
Eugenio Procaccini
Ferdinando Riccardi
P2860
P304
P356
10.1136/ESMOOPEN-2017-000176
P577
2017-06-02T00:00:00Z